Evidence map›Paper›PMID 32418341›Full record

ReviewMedical physics2020

Artificial intelligence-based clinical decision support in modern medical physics: Selection, acceptance, commissioning, and quality assurance.

Geetha Mahadevaiah, Prasad Rv, Inigo Bermejo, David Jaffray, Andre Dekker, Leonard Wee

Abstract readReview
In one paragraph

Review in Medical physics, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 36 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
36citing papers in PubMed, 1 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

36 citing papers in PubMed, 1 synthesis or guideline pooled it.

  1. Pooled it
  2. Article
  3. Article
  4. The 'Hippocratic Oath' for AI-based clinical decision support systems.BMC medical informatics and decision making · 2026
    Article
  5. Article
  6. Observational
  7. Article
  8. Article
  9. Review
  10. Article
  11. Article
  12. Review
  13. Review
  14. Review
  15. Article
  16. Article
  17. Article
  18. Article
  19. Review
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Geetha MahadevaiahPhilips Research India, Bangalore, 560045, India.
Prasad RvPhilips Research India, Bangalore, 560045, India.
Inigo BermejoDepartment of Radiation Oncology (MAASTRO), GROW School for Oncology and Developmental Biology, Maastricht University Medical Centre, Maastricht, 6229 ET, Netherlands.
David JaffrayPrincess Margaret Cancer Centre, University Health Network, Toronto, ON, M5G 2M9, Canada.
Andre DekkerDepartment of Radiation Oncology (MAASTRO), GROW School for Oncology and Developmental Biology, Maastricht University Medical Centre, Maastricht, 6229 ET, Netherlands.
Leonard WeeDepartment of Radiation Oncology (MAASTRO), GROW School for Oncology and Developmental Biology, Maastricht University Medical Centre, Maastricht, 6229 ET, Netherlands.

Funding

Netherlands Organisation for Scientific Research
6 · The paper itself

Abstract

backgroundRecent advances in machine and deep learning based on an increased availability of clinical data have fueled renewed interest in computerized clinical decision support systems (CDSSs). CDSSs have shown great potential to improve healthcare, increase patient safety and reduce costs. However, the use of CDSSs is not without pitfalls, as an inadequate or faulty CDSS can potentially deteriorate the quality of healthcare and put patients at risk. In addition, the adoption of a CDSS might fail because its intended users ignore the output of the CDSS due to lack of trust, relevancy or actionability.

aimIn this article, we provide guidance based on literature for the different aspects involved in the adoption of a CDSS with a special focus on machine and deep learning based systems: selection, acceptance testing, commissioning, implementation and quality assurance.

resultsA rigorous selection process will help identify the CDSS that best fits the preferences and requirements of the local site. Acceptance testing will make sure that the selected CDSS fulfills the defined specifications and satisfies the safety requirements. The commissioning process will prepare the CDSS for safe clinical use at the local site. An effective implementation phase should result in an orderly roll out of the CDSS to the well-trained end-users whose expectations have been managed. And finally, quality assurance will make sure that the performance of the CDSS is maintained and that any issues are promptly identified and solved.

conclusionWe conclude that a systematic approach to the adoption of a CDSS will help avoid pitfalls, improve patient safety and increase the chances of success.

Indexed as

Artificial IntelligenceDecision Support Systems, ClinicalPhysicsQuality Assurance, Health CareHumansartificial intelligenceclinical decision supportmachine learning

Identifiers

PMID32418341
PMCPMC7318221

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.